Sammy Farah
Director Ejecutivo en TURNSTONE BIOLOGICS CORP. .
Fortuna: - $ al 31/05/2024
Perfil
Sammy J.
Farah is currently the President, Chief Executive Officer & Director at Turnstone Biologics Corp.
and the Chief Executive Officer at Myst Therapeutics LLC.
Previously, he worked as an Investment Professional at Versant Venture Management LLC, the Chief Business Officer at Immune Design Corp., and the President at Synthetic Genomics Vaccines, Inc. He holds a doctorate degree from Stanford University, an MBA and a doctorate degree from the University of Pennsylvania, and an undergraduate degree from the Massachusetts Institute of Technology.
Participaciones conocidas en empresas públicas
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 19/04/2024 | 0 ( -.--% ) | - $ | 31/05/2024 |
Cargos activos de Sammy Farah
| Empresas | Cargo | Inicio |
|---|---|---|
| TURNSTONE BIOLOGICS CORP. | Director Ejecutivo | 01/10/2015 |
Turnstone Biologics, Inc.
 Turnstone Biologics, Inc. BiotechnologyHealth Technology Turnstone Biologics, Inc. develops bio-therapeutics for the treatment of cancer. It develops Maraba oncolytic viral immunotherapy, a platform representing a disruptive approach in the treatment of cancer. The company was founded by David Stojdl, Brian D. Lichty and John C. Bell and is headquartered in Ottawa, Canada. | Director Ejecutivo | - |
Myst Therapeutics LLC
 Myst Therapeutics LLC Miscellaneous Commercial ServicesCommercial Services Myst Therapeutics LLC develops novel T-cell therapies for solid tumors. The company is based in Glendale, CA. The CEO of the company is Sammy J. Farah. Myst Therapeutics was acquired by Turnstone Biologics, Inc. on January 20, 2021. | Director Ejecutivo | - |
Antiguos cargos conocidos de Sammy Farah.
| Empresas | Cargo | Fin |
|---|---|---|
| Synthetic Genomics Vaccines, Inc. | Presidente | 01/10/2015 |
Versant Venture Management LLC
 Versant Venture Management LLC Investment ManagersFinance Versant Venture Management LLC (Versant Ventures) is an independent venture capital firm founded in 1999 by Brian Atwood, Samuel Colella, Bill Link and Ross Jaffe. The firm is headquartered in San Francisco with additional offices in Basel and Vancouver. | Analista de Capital Privado | 31/05/2010 |
| IMMUNE DESIGN CORP | Corporate Officer/Principal | - |
Formación de Sammy Farah.
| Stanford University | Doctorate Degree |
| University of Pennsylvania | Doctorate Degree |
| Massachusetts Institute of Technology | Undergraduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 1 |
|---|---|
| TURNSTONE BIOLOGICS CORP. | Health Technology |
| Empresas privadas | 5 |
|---|---|
Versant Venture Management LLC
Versant Venture Management LLC Investment ManagersFinance Versant Venture Management LLC (Versant Ventures) is an independent venture capital firm founded in 1999 by Brian Atwood, Samuel Colella, Bill Link and Ross Jaffe. The firm is headquartered in San Francisco with additional offices in Basel and Vancouver. | Finance |
Immune Design Corp.
 Immune Design Corp. Pharmaceuticals: MajorHealth Technology Immune Design Corp. is a clinical-stage immunotherapy company focused on cancer with in vivo approaches designed to enable the body's immune system to fight disease. It develops multiple product candidates from its discovery platforms, ZVex and GLAAS. The company was founded by Steven G. Reed and David Baltimore on February 20, 2008 and is headquartered in Kenilworth, NJ. | Health Technology |
| Synthetic Genomics Vaccines, Inc. | |
Turnstone Biologics, Inc.
Turnstone Biologics, Inc. BiotechnologyHealth Technology Turnstone Biologics, Inc. develops bio-therapeutics for the treatment of cancer. It develops Maraba oncolytic viral immunotherapy, a platform representing a disruptive approach in the treatment of cancer. The company was founded by David Stojdl, Brian D. Lichty and John C. Bell and is headquartered in Ottawa, Canada. | Health Technology |
Myst Therapeutics LLC
Myst Therapeutics LLC Miscellaneous Commercial ServicesCommercial Services Myst Therapeutics LLC develops novel T-cell therapies for solid tumors. The company is based in Glendale, CA. The CEO of the company is Sammy J. Farah. Myst Therapeutics was acquired by Turnstone Biologics, Inc. on January 20, 2021. | Commercial Services |
- Bolsa de valores
- Insiders
- Sammy Farah
